AARTIDRUGSNSESeptember 26, 2023

Aarti Drugs Limited

1,691words
2turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
To, Listing/ Compliance Department BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 To, Listing/ Compliance Department National Stock Exchange of In
Rs. 100 crore
Listed On National Stock Exchange of India Limited 2017 Pinnacle Life Science Pvt. Ltd. crossed Rs. 100 crores turnover 2014 2023 Consolidated Revenue Rs. 2,700+ Cr 2020 Crossed Rs. 2,000 Cr Consolidate
Rs. 2,700
Pinnacle Life Science Pvt. Ltd. crossed Rs. 100 crores turnover 2014 2023 Consolidated Revenue Rs. 2,700+ Cr 2020 Crossed Rs. 2,000 Cr Consolidated Turnover & Rs. 200 Cr Formulations Turnover Crossed
Rs. 2,000
d. crossed Rs. 100 crores turnover 2014 2023 Consolidated Revenue Rs. 2,700+ Cr 2020 Crossed Rs. 2,000 Cr Consolidated Turnover & Rs. 200 Cr Formulations Turnover Crossed Rs. 200 Cr consolidated PAT
Rs. 200
014 2023 Consolidated Revenue Rs. 2,700+ Cr 2020 Crossed Rs. 2,000 Cr Consolidated Turnover & Rs. 200 Cr Formulations Turnover Crossed Rs. 200 Cr consolidated PAT Crossed Rs. 1,000 crores turnover
Rs. 200
Cr 2020 Crossed Rs. 2,000 Cr Consolidated Turnover & Rs. 200 Cr Formulations Turnover Crossed Rs. 200 Cr consolidated PAT Crossed Rs. 1,000 crores turnover formulation Entered through 100% subsi
Rs. 1,000 crore
idated Turnover & Rs. 200 Cr Formulations Turnover Crossed Rs. 200 Cr consolidated PAT Crossed Rs. 1,000 crores turnover formulation Entered through 100% subsidiary - Pinnacle Life Science Pvt. Ltd. 199
100%
ed Rs. 200 Cr consolidated PAT Crossed Rs. 1,000 crores turnover formulation Entered through 100% subsidiary - Pinnacle Life Science Pvt. Ltd. 1998 Crossed Rs. 100 crores turnover 4 Key Fact
Rs. 100 crore
formulation Entered through 100% subsidiary - Pinnacle Life Science Pvt. Ltd. 1998 Crossed Rs. 100 crores turnover 4 Key Facts & Figures Largest producer of Nimesulide in the world. Largest producer
4,261 MT
API Manufacturing Largest producer of Ketoconazole in the world 12 Manufacturing Facilities 4,261 MT/Monthly Capacity 80+ Finished Products 1,10,330 Sq.m Plant Area Largest producer of Metronida
38%
330 Sq.m Plant Area Largest producer of Metronidazole Benzoate in the world ~1,571 Employees ~38% Export Revenue Largest producer in Fluoroquinolones group in the world Largest producer of Tin
1 MT
bulk API in paper bags, usage of fibre drums instead of HDPE drums, packing bulk in jumbo bags (1 MT packing) to reduce excess use of plastic bags intermediates • For efficient utilization of util
Speaking time
Revenue
1
Captive consumption
1
Advertisement
Opening remarks
Captive consumption
Rs. 300 crores Revenue Growth Higher Margins Higher RoCE 10 11 Financial Highlights of FY23 and Q1FY24 FY 23 Result Highlights Rs. crores Revenue EBITDA & EBITDA Margin (%) PAT & PAT Margin (%) 13.7% 11.3% 8.2% 6.1% +9% 2,718 2,500 341 308 205 166 FY22 FY23 FY22 FY23 FY22 FY23 1. EBITDA includes other income & excludes exceptional items 13 Q1 FY24 Result Highlights Rs. crores Revenue EBITDA & EBITDA Margin (%) PAT & PAT Margin (%) +6.3% 742 622 661 10.8% 12.7% 12.8% 5.6% 7.6% 7.3% 94 85 67 56 48 35 Q1 FY23 Q4 FY23 Q1 FY24 Q1 FY23 Q4 FY23 Q1 FY24 Q1 FY23 Q4 FY23 Q1 FY24 1. EBITDA includes other income & excludes exceptional items 14 FY22 Segmental Break-up FY22 FY23 80% 11% 4% 5% 82% 10% 5% 3% API Formulation API Formulation Speciality Chemicals Intermediates & Others Speciality Chemicals Intermediates & Others 15 16 Historical Performance At A Glance Strong Financial Performance Revenue (Rs. Crores) EBITDA (Rs. Crores) PAT (Rs. Crores) Consolidat ed 2,718 2,500 2,159 1,808 1,563 442 28
Advertisement
← All transcriptsAARTIDRUGS stock page →